Navigation Links
Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009
Date:5/6/2009

failure of pixantrone to prove safe and effective for treatment of relapsed aggressive NHL as determined by the FDA, the possibility that the NDA submission will not be completed in the second quarter of 2009, that priority review will not be granted by the FDA and that a decision by the FDA is not rendered in late 2009, the possibility that we may not receive all of the additional amount owed to us by Spectrum, our ability to continue to raise capital as needed to fund its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in our filings with the Securities and Exchange Commission including, without limitation, our most recent filings on Forms 10-K, 8-K, and 10-Q. Except as may be required by law, we do not intend to update or alter our forward-looking statements whether as a result of new information, future events, or otherwise.

    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    F: 206.272.4434
    E: media@ctiseattle.com
    www.celltherapeutics.com/media.htm

    Investors Contact:
    Ed Bell
    T: 206.272.4345
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.celltherapeutics.com/investors.htm

                                              Three Months Ended
                                                   March 31,
                                                   ---------
                                                2009        2008
                                                ----        ----
    Revenues:
      Product sales                               $-      $3,374
      License and contract revenue                20          20
                                           
'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
2. Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections
3. Cornerstone Therapeutics to Host First Quarter 2009 Conference Call
4. Prime Therapeutics Announces Departure of President and Chief Executive Officer Timothy Dickman
5. InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer
6. Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug
7. TorreyPines Therapeutics, Inc. Hires Advisor to Evaluate Strategic Alternatives
8. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
9. Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis
10. Cell Therapeutics Initiating Rolling NDA Submission for Pixantrone
11. Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... DC (PRWEB) December 22, 2014 ... its year-long, professional development programs this month. Faculty ... which focuses on nurse educators fast-tracked for administrative ... the Leadership Development Program for Simulation Educators, featuring ... specialized area of nursing education. , Twenty ...
(Date:12/22/2014)... 22, 2014 Parker & Sons, Inc. ... in Arizona home contracting services reports a record number ... quality services in 2014. As a company that has ... 1970s, Parker and Sons is a business that is ... works side-by-side with other top quality companies in Arizona ...
(Date:12/21/2014)... (PRWEB) December 22, 2014 Recently, BambooFlooringChina.com, ... durable strand woven bamboo flooring collection , and launched ... 25%. The promotion is valid until Jan. 30, 2015. ... woven bamboo is the hardest bamboo flooring available today; ... resembling that of traditional teak hardwoods. Strand woven bamboo ...
(Date:12/21/2014)... BellasDress.com offers a wide range of women’s dresses, ... its BellasDress Christmas Sale , offering big discounts ... BellasDress is a famous online supplier of women’s dresses; ... series of promotions. The dress experts of the company ... are proud of offering high quality wedding dresses and ...
(Date:12/21/2014)... 21, 2014 When families in Coral Gables ... they call? The new answer is Lice Troopers . ... 33134, their newest treatment center will be the new go-to ... and without the use of harmful chemicals or pesticides. ... January 1, 2015. Like the company’s first clinic (located at ...
Breaking Medicine News(10 mins):Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2Health News:BellasDress.com Announces its BellasDress Christmas Sale 2Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2
... , Working Together to Share Records Safely, Improve ... of Veterans Affairs (VA) and Kaiser Permanente today announced an ... Nation,s heroes. VA and Kaiser Permanente are launching a pilot ... Nationwide Health Information Network (NHIN) created by the Department of ...
... ... of Feeding America,s SNAP Outreach Efforts , CHICAGO, Nov. 25 ... $1 million donation from the Bank of America Charitable Foundation to ... Nutrition Assistance Program (SNAP), formerly named the Food Stamp Program. ...
... to normal human development - the Wnt/Wingless (Wnt) and ... ways that can promote tumor cell invasion and metastasis, ... Cancer Center report in the Nov. 25 issue of ... involves three signaling components known to correlate with invasive ...
... Melvin R. Kaplan, MD, FACP, a former Board Chair ... became Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center ... Physicians for his lifetime devotion to the care of patients. ... American College of Physicians will present Dr. Kaplan with the ...
... 2009 Physicians at UT Southwestern Medical Center soon will ... patients with upper spinal-cord injuries or other diseases that keep ... St. Paul is only one of only two sites ... equipped to implant the device, called the NeuRx Diaphragm Pacing ...
... mitochondrial function plays in insulin production , WEDNESDAY, ... people with type 2 diabetes to lose insulin-producing ... treatments, U.S. researchers say. , Mitochondria provide energy ... when insulin-producing beta cells in the pancreas can,t ...
Cached Medicine News:Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 3Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:1 of LA BioMed's founders to be honored 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2
(Date:12/22/2014)... a privately-held medical products and technologies company, today announced ... Officer of the company, effective December 22, 2014. ... Board of Directors of ConvaTec thanks Mr. Berger for ... years," said Magnus Lundberg , the Chairman of ... company is well positioned for the future."  The company ...
(Date:12/22/2014)... and STOCKHOLM , Dec. ... (Sobi) and partner Auxilium Pharmaceuticals, Inc. today announced that ... of the European Medicines Agency (EMA) has adopted a ... histolyticum) for the treatment of adult men with Peyronie,s ... at least 30 degrees at the start of therapy. ...
(Date:12/22/2014)... , Dec. 22, 2014  Mark Farrah Associates ... providing a summary of the 2015 marketplace exchange ... trends.  According to a recent ... and Evaluation, Department of Health and Human Services) ... in individual medical plans through the Marketplace as ...
Breaking Medicine Technology:ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Insights into the Marketplace and Individual Market Growth 2
... , CINCINNATI , Feb. 2 ... mail-order online pharmacy, and PrimaryCareOne, a clinic-based health care program in ... today they have partnered to offer patients a 30-day supply of ...   Combined with PrimaryCareOne,s preventive primary health care program for as ...
... , PRINCETON, N.J. ... Board: SNGX) (Soligenix or the Company), a late-stage biotechnology company, ... February 2010 edition of Vaccine, which describes ... stability. The article was authored by the Company,s collaborators at ...
Cached Medicine Technology:HealthWarehouse.com and PrimaryCareOne Form Partnership to Provide Low Cost Prescription Medications to Patients 2HealthWarehouse.com and PrimaryCareOne Form Partnership to Provide Low Cost Prescription Medications to Patients 3HealthWarehouse.com and PrimaryCareOne Form Partnership to Provide Low Cost Prescription Medications to Patients 4Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 2Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 3Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 4Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 5Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 6Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin 7
Slick® Disposable Endotracheal Stylet, Nylon-coated wire, Malleable core, Sureloc Stop helps maintain desired length for patient safety. Handle forming capability for better grip. Sterile. Single...
... spine manipulation. Prevent dental and soft tissue ... alternative to X-ray. Light-guided intubation is based ... in the neck. This technique takes advantage ... relative to the esophagus. A well-defined, circumscribed ...
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
Medicine Products: